Christopher P. Schnittker
Profile
Mr. Christopher P.
Schnittker, CPA, is CFO & Principal Accounting Officer at CannaPharmaRx, Inc.
Mr. Schnittker was previously employed as Chief Financial Officer by Golden Dragon Holding Co., Chief Financial Officer, Treasurer & Senior VP by Echo Therapeutics, Inc., Secretary by Soligenix, Inc., Chief Financial Officer & Vice President by VioQuest Pharmaceuticals, Inc., Chief Financial Officer & Senior Vice President by Micromet, Inc., Chief Financial Officer by Cytogen Corp., Chief Financial Officer by Magainin Pharmaceuticals, Inc., Finance Director & Controller by Global Sports, Inc., a Manager-Internal Control by Rhone-Poulenc Rorer Pharmaceuticals, Inc., and a Member-Audit & Assurance Services Division by Pricewaterhouse LLP.
He received his undergraduate degree from Lafayette College.
Former positions of Christopher P. Schnittker
| Companies | Position | End |
|---|---|---|
| CANNAPHARMARX, INC. | Director of Finance/CFO | 17/12/2015 |
| ECHO THERAPEUTICS, INC. | Director of Finance/CFO | 14/07/2014 |
| VIOQUEST PHARMACEUTICALS, INC. | Director of Finance/CFO | 30/06/2009 |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Director of Finance/CFO | 09/12/2007 |
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
 Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Director of Finance/CFO | 30/04/2006 |
Training of Christopher P. Schnittker
| Lafayette College | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| VIOQUEST PHARMACEUTICALS, INC. | Health Technology |
| SOLIGENIX, INC. | Health Technology |
| CANNAPHARMARX, INC. | Process Industries |
| Private companies | 8 |
|---|---|
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Health Technology |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Health Technology |
Genaera Corp.
 Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
Echo Therapeutics, Inc.
 Echo Therapeutics, Inc. Medical SpecialtiesHealth Technology Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ. | Health Technology |
| Rhone-Poulenc Rorer Pharmaceuticals, Inc. | |
| Pricewaterhouse LLP | Commercial Services |
1075 First Global Associates LLC (Pennsylvania)
 1075 First Global Associates LLC (Pennsylvania) Internet RetailRetail Trade 1075 First Global Associates LLC provides e-commerce solutions and marketing services. It offers solutions for its partners through integrated e-commerce platform, which is comprised of three components: core technology, supporting infrastructure, and partner services. The company was founded in 1986 and is headquartered in Wilkes Barre, PA. | Retail Trade |
Golden Dragon Holding Co.
 Golden Dragon Holding Co. Financial ConglomeratesFinance Golden Dragon Holding Co. operates as a shell company. It intends to seek, investigate and acquire an interest in business opportunities. The company was founded in August 1998 and is headquartered in Denver, CO. | Finance |
- Stock Market
- Insiders
- Christopher P. Schnittker
